Garg Vipin K

CIK 00015158133 companiesDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001515813

Recent Transactions

50 trades

Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-02-02+18,950→ 18,950 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-02-02+18,950→ 363,364 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-02-02$6.64/sh−8,282→ 355,082 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-02-01+16,545→ 351,645 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-02-01+16,545→ 0 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-02-01$6.64/sh−7,231→ 344,414 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-31$5.18/sh+4,105→ 335,100 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-01-30+26,775→ 53,550 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-30$7.00/sh−11,701→ 330,995 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-30+26,775→ 342,696 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2025-01-27+164,800→ 164,800 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2025-01-27+477,500→ 477,500 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-25$6.98/sh−18,157→ 315,921 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2025-01-25+42,050→ 126,150 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2025-01-25+42,050→ 334,078 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2024-02-02−18,950→ 37,900 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-02-02$9.32/sh−8,376→ 292,028 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-02-02+18,950→ 300,404 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2024-02-01−16,545→ 16,545 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-02-01$9.88/sh−7,313→ 281,454 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-02-01+16,545→ 288,767 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-01-31$2.69/sh+7,889→ 272,222 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2024-01-30−26,775→ 80,325 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-01-30+26,775→ 276,030 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2024-01-30$9.80/sh−11,697→ 264,333 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2024-01-25+168,200→ 168,200 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2024-01-25+470,000→ 470,000 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-07-31$2.81/sh+126→ 249,255 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2023-02-02−18,950→ 56,850 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-02-02+18,950→ 257,551 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-02-02$15.04/sh−8,422→ 249,129 total
Exercise/Conversion
Altimmune, Inc.$ALT
Restricted Stock Units
2023-02-01−16,546→ 33,090 total
Exercise/Conversion
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-02-01+16,546→ 246,259 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-02-01$13.78/sh−7,658→ 238,601 total
Award
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2023-01-31$10.21/sh+1,938→ 229,713 total
Award
Altimmune, Inc.$ALT
Stock Options (option to buy)
2023-01-30+302,900→ 302,900 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2023-01-30+107,100→ 107,100 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-11-30$9.95/sh−3,007→ 227,775 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-10-30$12.77/sh−3,007→ 230,782 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-09-30$12.77/sh−3,008→ 233,789 total
Sale
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-08-31$20.02/sh−20,000→ 236,797 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-08-30$18.94/sh−3,007→ 256,797 total
Sale
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-08-12$15.06/sh−15,000→ 259,804 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-07-30$12.01/sh−3,007→ 274,804 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-06-30$11.70/sh−3,007→ 277,811 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-05-30$5.03/sh−3,008→ 280,818 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-04-30$4.52/sh−3,008→ 283,826 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-03-30$6.05/sh−3,007→ 286,834 total
Tax Payment
Altimmune, Inc.$ALT
Common Stock, par value $0.0001
2022-02-28$7.41/sh−3,007→ 289,841 total
Award
Altimmune, Inc.$ALT
Restricted Stock Units
2022-02-02+75,800→ 75,800 total

Companies

Recent Filings

Address

C/O TRANZYME, INC. 4819 EMPEROR BOULEVARD, SUITE 400

DURHAM, NC, 27703

View on SEC.gov